StockTalk: The secret sauce for medtech growth
Link copied to
StockTalk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses how to pick high-growth winners in the medtech sector.
Populating the experts panel this week is David McNamee, portfolio manager – Alpha Fund, Altor Capital; Michelle Gallaher, CEO of Opyl (ASX:OPL); and Ron Van der Pluijm, CEO of PKS Holdings (ASX:PKS).
The group discuss a range of topics, including how to pick a medtech startup primed for growth, key indicators of a strong revenue base, stock pics following the COVID-19 market correction and more.
So tune in above to hear the panel answer these questions and more.